J&J nearing deal to buy cancer drug maker Pharmacyclics: FT

March 4, 2015 11:31 PM

4 0

J&J nearing deal to buy cancer drug maker Pharmacyclics: FT

(Reuters) - Johnson & Johnson is close to buying cancer drug maker Pharmacyclics Inc in the coming days, the Financial Times reported, citing sources.

A bid from J&J is expected to value Pharmacyclics near its $17.5 billion market value or at a premium, FT said on Wednesday, citing people familiar with the matter.

Also read: 2 Abu Dhabi banks to merge into largest Gulf Arab bank

Read more

To category page

Loading...